19Labs

19Labs is a pioneering startup that addresses the significant challenge of providing healthcare access to millions in remote areas with its revolutionary product, GALE eClinic. The company, established in 2015, operates at the intersection of Consumer Electronics and Health Care, with headquarters in the United States. The recent $1.30M Seed Round investment on 25 January 2020 from Teal Ventures underscores its potential.

The GALE eClinic is a comprehensive telehealth solution that integrates over 25 smart diagnostic devices, including mobile ultrasounds, ECGs, and advanced blood testing tools. This solution effectively addresses the challenges faced by healthcare providers in remote and rural areas where equipping with proper diagnostic equipment is difficult and expensive. Moreover, it mitigates the shortage of physicians and clinicians, thus improving healthcare access.

Notably, GALE eClinic's ease of use enables even part-time community members to operate the devices, reducing operating costs by eliminating the need for full-time on-site personnel. A key feature is the capability for doctors from different organizations to collaborate, enabling them to conduct full medical exams from miles away. This not only empowers healthcare providers but also significantly enhances patient care, demonstrating the transformative impact of 19Labs in the healthcare industry.